Blog Post
Accessibility in Clinical Trials Isn’t Optional. It’s Foundational to Better Recruitment.Â
Patient recruitment has always been one of the most challenging…
How Specialization Is Reshaping Language Services
Explore how specialization is reshaping how global content gets executed…
Welo Life Sciences: Built for Life Sciences Translation, Regulatory Content, and Global ComplianceÂ
This is the environment where life sciences translation, regulatory content…
LangMark: A New Benchmark for AI Translation Post-Editing
Discover LangMark: A new benchmark dataset designed to evaluate and…
When Product Managers Ship Code, Global Readiness Can’t Be an AfterthoughtÂ
AI has collapsed execution costs, fundamentally changing where product risk…
EMA’s Guiding Principles on LLMs: Reshaping Regulatory Translation
Discover how the EMA’s Guiding Principles on LLMs are transforming…
How FDA and EMA Shape Linguistic Validation in Clinical Research
As clinical research becomes global, understanding how to meet regulatory…
Regulatory Compliance in Pharmacovigilance Translations: EMA, FDA, and MHRA Requirements Explained
As the range of medicinal products grows, regulatory bodies such…
Is Your Marketing Localization Strategy Ready for What’s Next? Trends for Global Teams
Global marketing is entering a new era. Explore these trends…
EUDAMED and the New Reality for Medical Device Companies
What increased transparency means for post-market surveillance and multilingual compliance.